Introduction
Hyperphenylalaninemia (HPA) results from " deficiency of the enzyme phenylalanine hydroxylase (PAH) or its cofactor, tetrahydrobiopterin (BH 4 ), Prompt diagnosis of neonates with HP A discovered by a newborn screening for phenylketonuria (PKU) is necessary, because early treatment by administration of BH4 and neurotransmitter precursors helps to prevent neurological injuryl . It is essential for the diffe-rential diagnosis to measure urinary pterin or specific enzyme activity. A BH4 loading test based on the lowering of serum phenylalanine is not essentia l but recommended as the simplest method. Recently, it has been reported that serum pheny lalanine concentrations decreased in some patients with PAHdeficient HPA after loading with BH 4 . By measuring serum pteridine levels and dihydropteridine reductase (DHPR) activities in all patients with HPA detected by the neonatal mass screening for PKU, we found some BPA patients without BH4 deficiency decreased their serum phenylalanine concentrations by the BH4 loading test.
Patients and Method
Twenty-five patients with HP A detected by neonatal mass-screening for PKU were examined from 1997 to 2000 . An oral BH4 loading test (10 mg/kg) was performed before starting a Phe-restricted diet. Blood samples were obtained at 0 , I , 2, 3, 4, 8, and 24 hours after loading. Serum phenylalanine concentrations were determined by using an automated amino acid analyzer. Serum pteridine levels were measured by using high performance liquid chromatography after iodine oxidation. DHPR activity was measured in Guthrie card specimens as described 2 •
Results
All patients with classical PKU (serum phenylalanine > 20 mgldL) showed no response to BH 4 • However, in five patients among fifteen identified with HPA (serum phenylalanine < 20 mg/dL), the serLim phenylalanine levels gradually decreased and the final pl, enylalanine concentrations after 24 hours were 2 to 5 mgldL lower than the initial phenylalanine concentrations . These five patients did not have abno rmalities in serum pteridine levels or DHPR activj 'Y.
Discussion
It is well known that an oral dose of BH4 (10 mg/kg) normalizes serum phenylalanine in patients with BH4 deficiency within 4-6 hours after loading unlike those with PKU . As PAH is normal in BH4 deficiency, it is possible that administered BH4 activates PAH in the liver and converts to tyrosine, thereby the blood phenylalanine level decreases and the blood tyrosine level increases . In PKU and HPA, which result from an abnormality in PAH production, it is not possible to activate P AH by administering BH 4 , and the blood phenylalanine level does not fall. Based on this principle, the BH4 loading test differentiates between the cofactor (BH4) deficiency and apoenzyme (PAH) deficiency.
Tn this study five patients with HP A had decreased serum phenylalanine levels at 24 hours after loading with BH 4 . Their serum phenylalanine va-lues did not decrease more than 3 mgldL during the first 4 hours, decreased 2 mgldL in one patient, and more than 3 mgldL in four patients from the initial value at 24 hours after loading. These responses differed from patients with BH4 defi-ciency. These patients had no abnormalities in serum pteridine levels or DHPR activity, and were diagnosed with PAH deficiency. 
Time after loading(hours) Fig. 2 : Response of serum phenylalanine concentrations after BH4 loading test (10 mg/kg) in patients with hyperphenylalaninemia (serum Phe <20 mg/dL). The serum Phe levels i.n five patients (shown in solid lines) gradually decreased and were 2 to 5 mg/dL lower than the initial Phe concentrations after 24 hours.
' . Recently, it has been reported that the mechanism of BH4 responsivfmess may be explained by distinct mutations in th~ PAH gene 3 • To summarize, a lowering of the serum phenylalanine value mc.y occur by administering BH4 which exceeds the M ichaelis constant (Km) when the rise of the Km value by the mutation in the P AH gene may be a cause. It \s important to confirm the response of BH4 loading \\'ith a second test. If the decrease of serum phenylalanine is more than 5mg/dL from the initial value, BR., can be used for the treatment of HP A with P AH defi ciency.
